Lantern Pharma, Inc. (LTRN)
3.85
+0.10
(+2.67%)
USD |
NASDAQ |
Jun 09, 11:07
Lantern Pharma EPS Diluted (Quarterly) : -0.2958 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Replimune Group, Inc. | -0.7694 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.329M |
| Total Expenses (Quarterly) | 3.329M |
| Enterprise Value | 35.94M |
| Earnings Yield | -37.53% |
| Normalized Earnings Yield | -37.53 |